Aemetis Inc. buy krebskrebs
Start price
25.01.21
/
50%
€4.10
Target price
25.01.22
€4.50
Performance (%)
101.22%
End price
26.01.22
€8.25
Summary
This prediction ended on 26.01.22 with a price of €8.25. The BUY prediction by krebskrebs for Aemetis Inc. saw massive gains of 101.22%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Aemetis Inc. | -0.633% | -0.633% | -47.915% | -82.556% |
iShares Core DAX® | 0.936% | 1.535% | 21.949% | 19.324% |
iShares Nasdaq 100 | 3.064% | 1.968% | 29.275% | 38.772% |
iShares Nikkei 225® | 1.898% | -0.295% | 14.740% | 1.986% |
iShares S&P 500 | 1.653% | 2.318% | 27.064% | 40.403% |
Comments by krebskrebs for this prediction
In the thread Aemetis Inc. diskutieren
Buy mit Kursziel 4,5
In the thread Trading Aemetis Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten